Rick E Winningham insider trades: Jazz Pharmaceuticals (JAZZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rick reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | JAZZ | ↓ Sell | 2,741 | $241.57 | $662K | Direct | May 27, 2026 (5d) |
| Nov 18, 2025 | JAZZ | ↓ Sell | 5,500 | $180.86 | $995K | Direct | Nov 20, 2025 (2d) |
| Aug 14, 2023 | JAZZ | ↓ Sell | 1,241 | $138.16 | $171K | Direct | Aug 15, 2023 (1d) |
| Dec 14, 2022 | TBPH | ↓ Sell | 50,000 | $11.19 | $560K | Direct | Dec 16, 2022 (2d) |
| Aug 8, 2022 | JAZZ | ↓ Sell | 1,089 | $152.32 | $166K | Direct | Aug 9, 2022 (1d) |
| Aug 6, 2021 | JAZZ | ↓ Sell | 1,306 | $147.96 | $193K | Direct | Aug 10, 2021 (4d) |
| Aug 7, 2020 | JAZZ | ↓ Sell | 931 | $125.87 | $117K | Direct | Aug 10, 2020 (3d) |
| Aug 9, 2019 | JAZZ | ↓ Sell | 726 | $135.65 | $98K | Direct | Aug 12, 2019 (3d) |
| Aug 10, 2018 | JAZZ | ↓ Sell | 16,639 | $176.18 | $2.9M | Direct | Aug 13, 2018 (3d) |
| Aug 11, 2017 | JAZZ | ↓ Sell | 662 | $142.37 | $94K | Direct | Aug 14, 2017 (3d) |
| Aug 11, 2017 | TBPH | ↑ Buy | 10,000 | $24.50 | $245K | Direct | Aug 11, 2017 (0d) |
| Jun 1, 2017 | JAZZ | ↓ Sell | 5,000 | $150.00 | $750K | Direct | Jun 2, 2017 (1d) |
| Aug 15, 2016 | JAZZ | ↓ Sell | 633 | $136.45 | $86K | Direct | Aug 17, 2016 (2d) |
| Aug 17, 2015 | TBPH | ↑ Buy | 80,000 | $11.86 | $949K | Direct | Aug 17, 2015 (0d) |
| Aug 10, 2015 | JAZZ | ↓ Sell | 801 | $180.00 | $144K | Direct | Aug 11, 2015 (1d) |
| Aug 12, 2014 | JAZZ | ↓ Sell | 1,087 | $133.15 | $145K | Direct | Aug 14, 2014 (2d) |
| Apr 17, 2014 | JAZZ | ↓ Sell | 27,500 | $140.00 | $3.9M | Direct | Apr 21, 2014 (4d) |
| Sep 12, 2013 | THRX | ↓ Sell | 22,353 | $40.03 | $895K | Direct | Sep 13, 2013 (1d) |
| Aug 13, 2013 | JAZZ | ↓ Sell | 1,070 | $81.86 | $88K | Direct | Aug 14, 2013 (1d) |
| Apr 30, 2013 | THRX | ↓ Sell | 255,532 | $33.64 | $8.6M | Direct | May 2, 2013 (2d) |
| Aug 3, 2012 | THRX | ↓ Sell | 75,749 | $27.95 | $2.1M | Direct | Aug 7, 2012 (4d) |
| May 11, 2011 | THRX | ↓ Sell | 127,746 | $26.34 | $3.4M | Direct | May 12, 2011 (1d) |
| Mar 1, 2011 | THRX | ↓ Sell | 63,873 | $22.53 | $1.4M | Direct | Mar 3, 2011 (2d) |
| Feb 28, 2011 | THRX | ↓ Sell | 252,300 | $22.24 | $5.6M | Direct | Feb 28, 2011 (0d) |
| Feb 23, 2011 | THRX | ↓ Sell | 266,400 | $21.35 | $5.7M | Direct | Feb 23, 2011 (0d) |
| Mar 11, 2008 | THRX | ↑ Buy | 20,000 | $10.47 | $209K | Direct | Mar 11, 2008 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other JAZZ insiders
Open-market trades in the last 12 months
About Rick E Winningham's insider trades
Rick E Winningham is a director at Jazz Pharmaceuticals (JAZZ). Since Mar 11, 2008, Rick has reported 3 open-market purchases worth $1.4M and 23 sales worth $38.8M on SEC Form 4. In the last 12 months: 2 sales ($1.7M).
Their filings also include shares withheld for taxes (62 filings), grants and awards (56 filings), option exercises (8 filings), gifts (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JAZZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.